A fragment-based approach for the discovery of isoform-specific p38? inhibitors
暂无分享,去创建一个
Maurizio Pellecchia | Ziming Zhang | John L. Stebbins | M. Pellecchia | J. Stebbins | Ziming Zhang | Xiyun Zhang | Jinhua Chen | Jinhua Chen | Randy Hoffman | Ambika Moore | Xiyun Zhang | R. Hoffman | A. Moore
[1] Maurizio Pellecchia,et al. The Nuclear Overhauser Effect in the lead identification process. , 2006, Current drug discovery technologies.
[2] Hans Peter Nestler. Combinatorial chemistry and fragment screening--two unlike siblings? , 2005, Current drug discovery technologies.
[3] Jens Meiler,et al. The INPHARMA method: protein-mediated interligand NOEs for pharmacophore mapping. , 2005, Angewandte Chemie.
[4] J. Boehm,et al. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.
[5] R. Griffey,et al. SAR by MS: a ligand based technique for drug lead discovery against structured RNA targets. , 2002, Journal of medicinal chemistry.
[6] Maurizio Pellecchia,et al. Targeting apoptosis via chemical design: inhibition of bid-induced cell death by small organic molecules. , 2004, Chemistry & biology.
[7] Markus Schade,et al. NMR fragment screening: tackling protein-protein interaction targets. , 2005, Current opinion in drug discovery & development.
[8] W. Patrick Walters,et al. A guide to drug discovery: Designing screens: how to make your hits a hit , 2003, Nature Reviews Drug Discovery.
[9] N. Gray,et al. Rational design of inhibitors that bind to inactive kinase conformations , 2006, Nature chemical biology.
[10] B. Shoichet,et al. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.
[11] Andrew R. Leach,et al. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery , 2001, J. Chem. Inf. Comput. Sci..
[12] M. Uesugi,et al. [Discovering high-affinity ligands for proteins: SAR by NMR]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[13] J. Madwed,et al. Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate. , 2002, Journal of medicinal chemistry.
[14] Christopher W Murray,et al. Fragment-based lead discovery using X-ray crystallography. , 2005, Journal of medicinal chemistry.
[15] L. Tong,et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site , 2002, Nature Structural Biology.
[16] Jerry L. Adams,et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.
[17] M. Congreve,et al. A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.
[18] Daniel A. Erlanson,et al. Fragment‐Based Drug Discovery. , 2004 .
[19] Maurizio Pellecchia,et al. Solution nuclear magnetic resonance spectroscopy techniques for probing intermolecular interactions. , 2005, Chemistry & biology.
[20] E. Jaeger,et al. Comparison of automated docking programs as virtual screening tools. , 2005, Journal of Medicinal Chemistry.
[21] M. Congreve,et al. Fragment-based lead discovery , 2004, Nature Reviews Drug Discovery.
[22] J. Irwin,et al. ZINC ? A Free Database of Commercially Available Compounds for Virtual Screening. , 2005 .
[23] Ajay,et al. The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. , 1999, Chemistry & biology.
[24] B. Shoichet,et al. High-throughput assays for promiscuous inhibitors , 2005, Nature chemical biology.
[25] Johan Schultz,et al. Structure-based screening as applied to human FABP4: a highly efficient alternative to HTS for hit generation. , 2002, Journal of the American Chemical Society.
[26] D E Griswold,et al. Inhibition of p38 MAP kinase as a therapeutic strategy. , 2000, Immunopharmacology.
[27] Maurizio Pellecchia,et al. Structure–activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid , 2006, Proceedings of the National Academy of Sciences.
[28] Maurizio Pellecchia,et al. SAR by ILOEs: an NMR-based approach to reverse chemical genetics. , 2006, Chemistry.
[29] Vicki L. Nienaber,et al. Discovering novel ligands for macromolecules using X-ray crystallographic screening , 2000, Nature Biotechnology.